Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP and SEFH

Garrido, Pilar; Aldaz, Azucena; Calleja, Miguel Ángel; Álava, Enrique de; Lamas, María Jesús; Martín, Miguel; Matias-Guiu, Xavier; Palacios, José; Vera, Ruth

doi:https://doi.org/10.7399/fh.10877

View/Open

farhos_a2017v4n6p688.pdf (226.0Kb)

Issue date

2017

Author

Garrido, Pilar

Aldaz, Azucena

Calleja, Miguel Ángel

Álava, Enrique de

Lamas, María Jesús

Martín, Miguel

Matias-Guiu, Xavier

Palacios, José

Vera, Ruth

Suggested citation

Garrido, Pilar; Aldaz, Azucena; Calleja, Miguel Ángel; Álava, Enrique de; Lamas, María Jesús; Martín, Miguel; ... Vera, Ruth. (2017) . Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP and SEFH. Farmacia Hospitalaria, 2017, vol. 41, núm. 61, p. 688-691. https://doi.org/10.7399/fh.10877.

Abstract

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual,

as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology (SEOM), Pathology (SEAP), and Hospital Pharmacy (SEFH) we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.

URI

http://hdl.handle.net/10459.1/62322

DOI

https://doi.org/10.7399/fh.10877

Is part of

Farmacia Hospitalaria, 2017, vol. 41, núm. 61, p. 688-691

Collections

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as cc-by-nc-nd (c) Garrido et al., 2017